Nutrition

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows

FDA Alerts

Rheumatologic disorders
Rheumatologic disorders
FDA Approves New Biosimilar
10/31/2018
10/31/2018
Rheumatologic disorders
Rheumatologic disorders
FDA Approves New Biosimilar
10/31/2018
10/31/2018
Rheumatologic disorders
Rheumatologic disorders
FDA Approves New Biosimilar
10/31/2018
10/31/2018
menopause
menopause
FDA Approves Menopausal Status Test
10/26/2018
The FDA has approved a test to help determine a patient’s menopau
10/26/2018
Influenza
Influenza
FDA: New Influenza Treatment
10/24/2018
The US Food and Drug Administration has approved baloxavir marboxil (Xofluza)
10/24/2018
Influenza
Influenza
FDA: New Influenza Treatment
10/24/2018
The US Food and Drug Administration has approved baloxavir marboxil (Xofluza)
10/24/2018
Influenza
Influenza
FDA: New Influenza Treatment
10/24/2018
The US Food and Drug Administration has approved baloxavir marboxil (Xofluza)
10/24/2018
FDA
FDA
Despite Warnings, Many Supplements Still Contain Undeclared Ingredients
10/15/2018
More than 50% of adults in the US have reported consuming dietary supplements, according to the study authors. However, warnings from the FDA of potential undeclared, unapproved pharmaceutical ingredients...
10/15/2018
FDA
FDA
Despite Warnings, Many Supplements Still Contain Undeclared Ingredients
10/15/2018
More than 50% of adults in the US have reported consuming dietary supplements, according to the study authors. However, warnings from the FDA of potential undeclared, unapproved pharmaceutical ingredients...
10/15/2018
FDA
FDA
Despite Warnings, Many Supplements Still Contain Undeclared Ingredients
10/15/2018
More than 50% of adults in the US have reported consuming dietary supplements, according to the study authors. However, warnings from the FDA of potential undeclared, unapproved pharmaceutical ingredients...
10/15/2018